ALNY vs QTWO · P/E 76, rev $1.29B vs rev $436.3M
Alnylam Pharmaceuticals Inc (ALNY) versus Q2 Holdings (QTWO) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Q2 Holdings (QTWO) is a software - application company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported QTWO revenue for 2026-06-30 was $436.3M. Net income was $56.5M. QTWO currently screens at market cap $5.77B.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. QTWO currently screens at market cap $5.77B.
Not investment advice. Open the ALNY and QTWO stock pages for the full models.
Not investment advice.